Clinical Trial Update: Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial update for selexipag in schistosomiasis-associated pulmonary arterial hypertension is reported as ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Schistosomiasis

Drugs mentioned

• Selexipag (selexipag)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Pulmonary Hypertension, Schistosomiasis | Phase 2 | Status: UNKNOWN